A panel of advisers to the U.S. Food and Drug Administration voted to place a widely used peptide called BPC-157 on a list that would allow broader pharmacy compounding.
Eight panel members voted in favor, while six members voted against it. One member abstained.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
Close to home. Always in the loop.
A low-commitment monthly bundle that keeps your business in front of local audiences across HyperLocal Loop and the OBBM Network.
Every Patriot Package is priced at over 40% off standard AdRevv list rates — and the discount deepens as you scale, up to 60% off at the Enterprise tier.
Need a custom configuration? Build your own package →
Add the app to your home screen for a faster, full-screen experience.
